BioCentury
ARTICLE | Clinical News

Levitra vardenafil: Phase III; NDA filed

September 30, 2002 7:00 AM UTC

In a placebo-controlled, double-blind Phase III trial in 805 men with erectile dysfunction (ED) for more than six months, 77% of men taking 10 mg and 74% of those taking 20 mg of vardenafil reported s...